Latest Discussions

Latest Specialty News

  • A group of researchers from Columbia University, Rutgers University and institutions in Europe and Japan have identified genomic alterations in pediatric relapsed acute lymphoblastic leukemia (ALL) that cause both therapy resistance and improved clinical response to multi-agent chemotherapy treatment. Rutgers Cancer Institute of New Jersey researcher Hossein Khiabanian, Ph.D., an assistant professor of pathology, was involved in the work in the Rabadan and Ferrando laboratories at Columbia University.
  • Terminal cancer patients in the United Kingdom are not getting strong pain treatment in a timely manner, say researchers. The median time between the first prescription of a "strong" opioid and death was only 9 weeks, according to a study of a representative population sample of advanced cancer patients in the United Kingdom. The study was published online Sept. 15 in Pain.
  • Tumors have a voracious appetite for fat and rely on hastened fat synthesis in cancer cells to satisfy their need. Now, a new study shows it is possible to use drugs to shut down fat synthesis in cancer cells to stunt tumor growth without harming healthy cells.

How to Login

How To Update Your Profile

How to Post & Reply to a Discussion

How to Add a Personal Contact

How to Post to the Library

Most Active Members